欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
CZ/H/0741/002
药品名称
Preglenix
活性成分
pregabalin 150.0 mg
剂型
Capsule, hard
上市许可持有人
Glenmark Pharmaceuticals s.r.o.
参考成员国 - 产品名称
Czechia (CZ)
PREGLENIX
互认成员国 - 产品名称
Slovakia (SK)
Preglenix 150 mg tvrdé kapsuly
许可日期
2015/06/24
最近更新日期
2024/03/07
药物ATC编码
N03AX16 pregabalin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
common_lab_30092021_clean_r001_d40
Date of last change:2024/09/06
Final Product Information
|
common_pil_clean_r001_d60
Date of last change:2024/09/06
Final PL
|
common_pl_clean_v020
Date of last change:2024/09/06
Final Product Information
|
common_spc_30092021_clean_r001_d40
Date of last change:2024/09/06
Final SPC
|
common_spc_clean_v020
Date of last change:2024/09/06
Final Labelling
|
Preg_common_lab_v006_clean
Date of last change:2024/09/06
PubAR
|
PAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase